[go: up one dir, main page]

MX2009003051A - Derivados de quinolinona. - Google Patents

Derivados de quinolinona.

Info

Publication number
MX2009003051A
MX2009003051A MX2009003051A MX2009003051A MX2009003051A MX 2009003051 A MX2009003051 A MX 2009003051A MX 2009003051 A MX2009003051 A MX 2009003051A MX 2009003051 A MX2009003051 A MX 2009003051A MX 2009003051 A MX2009003051 A MX 2009003051A
Authority
MX
Mexico
Prior art keywords
6alkyl
alk
pyridyl
substituted
6alkyloxy
Prior art date
Application number
MX2009003051A
Other languages
English (en)
Inventor
Bart Rudolf Romanie Kesteleyn
Dominique Louis Nestor Ghislain Surleraux
Geerwin Yvonne Paul Hache
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37807936&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009003051(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of MX2009003051A publication Critical patent/MX2009003051A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/60—Quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
    • C07F9/65685—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine oxide or thioxide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)

Abstract

Compuestos inhibidores del VIH de fórmula: incluidas las formas estereoisoméricas, las sales farmacéuticamente aceptables y los solvatos farmacéuticamente aceptables de dichos compuestos; donde R1 es ciano; R2 es H, alquiloC1-6, trifluorometilo, amino, mono- o di-alquilC1-6amino, alquilC1-6amino donde el grupo alquiloC1-6 puede estar sustituido; X1 es CH o N; R3 es fenilo o piridilo, cada uno de los cuales no está sustituido o está sustituido; R4 es H, alquiloC1-6, (alquilC1-6carbonilamino)alquiloC1-6-, Ar, tienilo opcionalmente sustituido, furanilo piridilo, pirimidilo, pirazinilo, pirrolilo, pirazolilo, imidazolilo, triazolilo, oxazolilo, tiazolilo, halo, trifluorometilo, hidroxi, alquiloxiC1-6, -OPO(OH)2, amino, aminocarbonilo, ciano -Y1-R6, -Y1-Alq-R6 o -Y1-Alq-Y2-R7; R5 es H, halo, hidroxi o alquiloxiC1-6; o R4 y R5 forman -O-CH2-O-; Y1 es O o NR8; Y2 es O o NR9; Alq es alquiloC1-6 bivalente; R6 es pirrolidinilo, piperidinilo, morfolinilo, piperazinilo, 4-alquilC1-6piperazinilo, 4-(alquilC1-6carbonil)piperazinilo, piridilo o imidazolilo; R7 es H, alquiloC1-6, hidroxialquiloC1-6, alquilC1-6carbonilo; R8 y R9 son H o alquiloC1-6; Ar es fenilo opcionalmente sustituido; composiciones farmacéuticas que comprenden los compuestos (I) anteriorescomoingrediente activo.
MX2009003051A 2006-09-29 2007-09-28 Derivados de quinolinona. MX2009003051A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121586 2006-09-29
PCT/EP2007/060289 WO2008037784A1 (en) 2006-09-29 2007-09-28 Quinolinone derivatives

Publications (1)

Publication Number Publication Date
MX2009003051A true MX2009003051A (es) 2009-04-01

Family

ID=37807936

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003051A MX2009003051A (es) 2006-09-29 2007-09-28 Derivados de quinolinona.

Country Status (13)

Country Link
US (1) US20100087649A1 (es)
EP (1) EP2074099A1 (es)
JP (1) JP2010504945A (es)
CN (1) CN101516853A (es)
AR (1) AR063059A1 (es)
AU (1) AU2007301958A1 (es)
BR (1) BRPI0717089A2 (es)
CA (1) CA2660377A1 (es)
CL (1) CL2007002812A1 (es)
MX (1) MX2009003051A (es)
RU (1) RU2009116264A (es)
TW (1) TW200829554A (es)
WO (1) WO2008037784A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106187889B (zh) * 2015-04-29 2021-11-05 中国科学院上海药物研究所 一种多官能团吖啶类化合物及其衍生物的制备方法
CN107652198B (zh) * 2017-10-09 2020-04-07 新乡市锦源化工有限公司 乙酰苯胺的制备方法
CN110540553B (zh) * 2019-09-23 2022-11-01 江西师范大学 含磷的喹啉类化合物及其制备方法和应用
AR120823A1 (es) 2019-12-23 2022-03-23 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos útiles como activadores de células t
WO2021254529A1 (zh) * 2020-07-14 2021-12-23 江苏先声药业有限公司 双环类化合物
WO2022053022A1 (zh) * 2020-09-12 2022-03-17 赛诺哈勃药业（成都）有限公司 甲硫氨酸腺苷转移酶抑制剂、其制备方法及应用
WO2022063128A1 (zh) * 2020-09-24 2022-03-31 上海凌达生物医药有限公司 一类芳环或芳基杂环并吡啶酮类化合物、药物组合物及其应用
US20250221979A1 (en) * 2022-03-29 2025-07-10 Shouyao Holdings (beijing) Co., Ltd. Novel heterocyclic compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613591A1 (de) * 1996-04-04 1997-10-09 Hoechst Ag Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH1171351A (ja) * 1997-08-29 1999-03-16 Ss Pharmaceut Co Ltd 置換キノロン誘導体及びこれを含有する医薬
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same

Also Published As

Publication number Publication date
AU2007301958A1 (en) 2008-04-03
CA2660377A1 (en) 2008-04-03
CN101516853A (zh) 2009-08-26
RU2009116264A (ru) 2010-11-10
TW200829554A (en) 2008-07-16
CL2007002812A1 (es) 2008-04-18
EP2074099A1 (en) 2009-07-01
US20100087649A1 (en) 2010-04-08
JP2010504945A (ja) 2010-02-18
WO2008037784A1 (en) 2008-04-03
BRPI0717089A2 (pt) 2013-11-26
AR063059A1 (es) 2008-12-23

Similar Documents

Publication Publication Date Title
MX2009003051A (es) Derivados de quinolinona.
NO20064400L (no) Prolin-derivater, og anvendelse av samme som inhibitorer av dipeptidyl peptidase IV
NO20083434L (no) Benzamid- og heteroarenderivater
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
TW200510431A (en) Quinazoline derivatives
NO20091409L (no) Pyridin-3-yl-derivater som immunmodulerende midler
NO20091889L (no) Inhibitorer av spiroketon acetyl-CoA karboksylase
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
NO20070445L (no) Pyrimidinderivater.
NO20024177L (no) Farmasöytiske preparater inneholdende azetidinderivater, de nye azetidinderivater og deres fremstilling
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
NO20074703L (no) Antibakterielle piperidinderivater
MX367154B (es) Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico.
NO20060973L (no) Pyridylderivater og deres anvendelse som tempeutiske midler
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
MY186650A (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
MX2012006962A (es) Inhibidores de la esfingosina quinasa.
MX2007004302A (es) Inhibidores de pi3 cinasa gamma para el tratamiento de anemia.
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
NO20052182L (no) Nye forbindelser
MX2007003913A (es) Alquil-piridinas como inhibidores de 11 beta para diabetes.
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal